Vivos Funzjoni Primarja: Sistema ta' Kirurġija Oftalmika minn Olcayto Guelec and David Geuder

Id-disinn Vivos Funzjoni Primarja: Sistema ta' Kirurġija Oftalmika minn Olcayto Guelec and David Geuder huwa rebbieħ stmat ħafna tal-prestiġjuż 2026 Premju A' Design Award tad-Deheb fil-Kategorija tal-Kompetizzjoni ta' Disinn ta' Apparati u Tagħmir Mediku.

DehebProdott Mediku· 2026

Vivos Funzjoni Primarja: Sistema ta' Kirurġija Oftalmika

minn Olcayto Guelec and David Geuder

Klijent: Geuder AG

Rebbieħ tal-Premju A' Design Award tad-Deheb fil-Kategorija ta' Prodott Mediku

56,783

Rebbieħ ta' Premju Ivverifikat

Ivverifika l-Istatus tal-Premju għal #182492

Ara fuq A' Design Award Stqarrija għall-Istampa Badge tal-Premju

Kuluri

Id-Disinn

Dwar Vivos Funzjoni Primarja: Sistema ta' Kirurġija Oftalmika

Test tal-Ktieb: Vivos jiddefinixxi mill-ġdid l-istazzjon tax-xogħol kirurġiku bħala pjattaforma li tevolvi flimkien mal-ambizzjoni klinika. Tliet konfigurazzjonijiet, Core, Nova, u Nova+, jestendu l-kapaċità mingħajr sostituzzjoni tas-sistema, l-unika arkitettura ta' titjib tat-tip tagħha fil-kirurġija oftalmika. Interfaċċa waħda, validata b'91.7 fil-mija sodisfazzjon mal-ewwel użu mingħajr taħriġ minn qabel, tirrifletti disinn mibni madwar il-kirurgu aktar milli l-proċedura. Konnessjonijiet tal-istrumenti mdawla, materjali raffinati u dettalji miżmuma jagħtu lit-tagħmir preżenza kalma u kunfidenti, ħielsa mill-istorbju viżiv tipiku tal-kategorija.

Ir-Rikonoxximent

Dwar il-Premju A' Design Award tad-Deheb

Vivos Funzjoni Primarja: Sistema ta' Kirurġija Oftalmika huwa rebbieħ tal-Premju A' Design Award tad-Deheb, rikonoxximent prestiġjuż ħafna mogħti lil disinji tal-ewwel klassi, mill-isbaħ u eċċellenti. Ir-rebbieħa tad-Deheb huma ħolqien innovattiv ħafna, b'viżjoni u li jleqqu b'mod li jgħammex, li jirriflettu t-talent, l-għerf u l-ħila tad-disinjaturi tagħhom. Huwa mistenni li Vivos Funzjoni Primarja: Sistema ta' Kirurġija Oftalmika ikun invenzjoni mfaħħra ħafna, li tistabbilixxi x-xejriet u monumentali li tagħti valur bla preċedent. Dan id-disinn rebbieħ tad-Deheb huwa proġett spettakolari u rispettat li jwessa' l-fruntieri tal-arti, ix-xjenza, id-disinn u t-teknoloġija. Vivos Funzjoni Primarja: Sistema ta' Kirurġija Oftalmika joħloq xewqa qawwija, iqajjem il-passjoni, iħeġġeġ il-kreattività u jisħer lilna.

Wara d-Disinn

Kit għall-Istampa

Krediti, membri tat-tim u dettalji tekniċi pprovduti mid-disinjatur.

Proprjetajiet Uniċi: Vivos is the only ophthalmic surgery system that grows with clinical needs. Core for cataract. Nova adds vitrectomy. Plus adds laser. One platform. One interface. One training investment. Independent usability validation confirmed 92 percent user satisfaction among first time users. Illuminated connection sockets were rated positively by all study participants. Premium materials and restrained detailing give the device a likeable presence without the visual noise typical of the category.
Dimensjonijiet u Ippakkjar: Display: 24 inch capacitive touchscreen. Vitrectomy: up to 40000 cuts per min. Vacuum: up to 700 mmHg, highest in category. Phacoemulsification: 53 kHz piezoelectric. IOP: active real-time (VIVOS Balance). Endolaser: 532 nm. Illumination: SOLEA LED, 16.9M colours, 2 ports, Retina Protection Mode. CE pending, submitted Feb 2026. ISO 13485 2016.
Tikketti: Ophthalmic Surgery System, Medical Device Design, Phacoemulsification, Vitrectomy, Modular Medical Platform, Surgical Ergonomics, Workflow Design, German Medical Engineering, Usability Validation, Premium Medical Aesthetics
Teknoloġija tal-Produzzjoni: Medical-grade polycarbonate housing, antimicrobial surface coating rated for over 10,000 disinfection cycles. Piezoelectric phacoemulsification at 53 kHz with beveled-up probe geometry for optimised fluidics. Pneumatic vitrectomy probe up to 40,000 cuts/min. IEC 60601-1 compliant. Modular quick-change cassette - single or multi-patient - tool-free exchange. Compatible with older phaco handpieces, protecting prior investment. Individually assembled in Heidelberg. ISO 13485:2016, IEC 62366-1, IEC 60601-1, CE pending
Sfida tad-Disinn: The central challenge was integrating six surgical functions, historically distributed across two to three separate devices, into a single platform without increasing cognitive load. Internally, decades of segmented product architecture and a 75-year heritage required rethinking established engineering logic. Externally, MDR regulations, IEC 62366 1 usability standards and strict OR hygiene constraints limited design freedom. Maintaining identical UX across Core, Nova and Plus while ensuring durability for thousands of cleaning cycles demanded systemic redesign rather than incremental improvement.
Riċerka: Usability research was conducted. Objective: reduce cognitive load without limiting clinical capability. Methodology: iterative co-design workshops with surgeons, Geuder teams and engineering, followed by independent summative validation per IEC 62366-1. Data collection included usability testing and task-based evaluations. Participants: 13 first-time users at RWTH Aachen University, 2026. Results: 91.7% satisfaction, no unacceptable residual risks. Insights validated the workflow UI, surgeon profiles and illuminated sockets, contributing to greater efficiency, improved patient safety and long-term system adoption in clinical practice.
Ispirazzjoni: Ophthalmic surgery is precise. Why should its devices remain fragmented, complex and visually uninspiring. Anterior and posterior procedures require separate investments, training and ecosystems not because clinical need requires it but because no manufacturer redesigned the architecture around the surgeon. Geuder AG with seventy five years of ophthalmic expertise asked what if one platform could grow without hardware replacement. Validated by independent study and unique in its modular upgrade logic.
Tul tal-Proġett: The project was developed in Heidelberg, Germany by Geuder AG. Development spanned multiple months with iterative design and engineering phases conducted in close collaboration with ophthalmic surgeons and operating room nursing staff. Summative usability validation was performed at RWTH Aachen University in early 2026. CE Mark application was submitted on 27 February 2026. Public market launch is scheduled for June 2026.
Fluss tal-Operazzjoni: Before each procedure, the surgeon selects a personal profile, preloading preferred settings and pedal sensitivity. A three-column touchscreen maps each surgical step as a visual sequence. Colour-coded modules allow instant identification in a darkened theatre. Illuminated sockets guide instrument connection by touch. The foot pedal, with individually adjustable actuation force, controls fluid flow and laser hands-free. Eye pressure is monitored and adjusted in real time.
Membri tat-Tim: Collaboration between Geuder AG's Engineering, Quality Management, Regulatory Affairs, Product Management, Service, Application, Development, and Sales departments.
Krediti tal-Immaġni: Photography Geuder AG, 2026